Myocardial Infarction

• FDA approval · 2014-11-03
  FDA Approved: CAPTOPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved Hikma Pharmaceuticals USA's supplemental application for captopril (CAPTOPRIL), enabling the generic captopril product under th…

• FDA approval · 2014-10-31
  FDA Approved: LISINOPRIL — Supplemental Application (Solco healthcare U.S., LLC)

  The FDA approved a supplemental application for lisinopril from Solco Healthcare U.S., LLC.

• FDA approval · 2014-10-30
  FDA Approved: LOPRESSOR — Supplemental Application (Validus Pharmaceuticals LLC)

  FDA approved a supplemental application for Lopressor (metoprolol tartrate) from Validus Pharmaceuticals LLC.

• FDA approval · 2014-10-28
  FDA Approved: METOPROLOL TARTRATE — Original Application (TRUPHARMA LLC)

  FDA approved TRUPHARMA LLC's original ANDA for metoprolol tartrate, enabling a generic version of this beta-blocker. The approval makes meto…

• FDA approval · 2014-09-26
  FDA Approved: RAMIPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for RAMIPRIL from Hikma Pharmaceuticals USA Inc. under ANDA077900.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2014-09-25
  FDA Approved: QUINAPRIL — Supplemental Application (Chartwell RX, LLC)

  The FDA approved a supplemental application for Quinapril from Chartwell RX, LLC, authorizing a generic quinapril product under an ANDA.

• FDA approval · 2014-09-15
  FDA Approved: CLOPIDOGREL BISULFATE — Original Application (RADHA PHARMACEUTICALS, INC.)

  FDA approved the original ANDA for clopidogrel bisulfate, a generic antiplatelet agent, expanding access to a therapy that reduces vascular …

• FDA approval · 2014-09-04
  FDA Approved: TRANDOLAPRIL — Supplemental Application (Epic Pharma, LLC)

  FDA approved a supplemental application for Trandolapril tablets from Epic Pharma, LLC.

• FDA approval · 2014-08-27
  FDA Approved: METOPROLOL TARTRATE — Original Application (Almaject, Inc.)

  FDA approved Almaject, Inc.'s metoprolol tartrate as an original Abbreviated New Drug Application (ANDA), establishing a generic version of …

• FDA approval · 2014-07-28
  FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)

  The FDA approved a supplemental application from Prasco Laboratories for the fixed-dose combination of amlodipine and atorvastatin (amlodipi…

• FDA approval · 2014-07-19
  FDA Approved: METOPROLOL TARTRATE — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for metoprolol tartrate filed by Aurobindo Pharma Limited.

• FDA approval · 2014-06-13
  FDA Approved: LISINOPRIL — Supplemental Application (Aurobindo Pharma Limited)

  The FDA granted a supplemental approval for lisinopril under ANDA077622 for Aurobindo Pharma Limited.

• FDA approval · 2014-06-12
  FDA Approved: CLOPIDOGREL BISULFATE — Supplemental Application (Dr.Reddy's Laboratories Limited)

  FDA approved a supplemental application for clopidogrel bisulfate from Dr. Reddy's Laboratories Limited. This action confirms approval of th…

• FDA approval · 2014-06-11
  FDA Approved: CLOPIDOGREL — Supplemental Application (Aurobindo Pharma Limited)

  The FDA approved a supplemental application to authorize a generic clopidogrel bisulfate product from Aurobindo Pharma Limited.

• FDA approval · 2014-04-11
  FDA Approved: CLOPIDOGREL — Original Application (Amneal Pharmaceuticals LLC)

  The FDA approved Amneal Pharmaceuticals LLC's original application for clopidogrel, enabling a generic version of the antiplatelet medicatio…

• FDA approval · 2014-03-04
  FDA Approved: CLOPIDOGREL — Original Application (Apotex Corp.)

  FDA approved Apotex Corp.'s original generic application for clopidogrel bisulfate (clopidogrel).

• FDA approval · 2013-12-31
  FDA Approved: FOSINOPRIL SODIUM — Supplemental Application (Aurobindo Pharma Limited)

  FDA approved a supplemental application for fosinopril sodium from Aurobindo Pharma Limited.

• FDA approval · 2013-12-12
  FDA Approved: PLAVIX — Supplemental Application (Sanofi-Aventis U.S. LLC)

  The FDA approved a supplemental application for Plavix (clopidogrel) submitted by Sanofi-Aventis U.S. LLC.

• FDA approval · 2013-10-30
  FDA Approved: BRILINTA — Supplemental Application (AstraZeneca Pharmaceuticals LP)

  The FDA approved a supplemental application for BRILINTA (ticagrelor) submitted by AstraZeneca Pharmaceuticals LP.

• FDA approval · 2013-10-29
  FDA Approved: LISINOPRIL — Original Application (Exelan Pharmaceuticals Inc.)

  FDA approved Exelan Pharmaceuticals’ Original Application for lisinopril, a generic ACE inhibitor, marking the availability of a generic lis…

• FDA approval · 2013-08-16
  FDA Approved: LISINOPRIL — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.(780779901))

  FDA approved a supplemental application for generic lisinopril from Heritage Pharmaceuticals (d/b/a Avet Pharmaceuticals), authorizing a cha…

• FDA approval · 2013-08-14
  FDA Approved: LISINOPRIL — Supplemental Application (Actavis Pharma, Inc.)

  FDA approved a supplemental application for lisinopril from Actavis Pharma, Inc., authorizing the marketing of a generic lisinopril product.

• FDA approval · 2013-05-20
  FDA Approved: HEPARIN SODIUM — Supplemental Application (Hospira, Inc.)

  FDA approved a supplemental application for Hospira's heparin sodium, indicating a modification to the product's approval (likely labeling o…

• FDA approval · 2013-05-14
  FDA Approved: CARVEDILOL — Supplemental Application (Aurobindo Pharma Limited)

  The FDA approved a supplemental application for carvedilol from Aurobindo Pharma Limited, granting approval of an additional generic carvedi…

• FDA approval · 2013-05-07
  FDA Approved: CARVEDILOL — Supplemental Application (Dr. Reddy's Laboratories Limited)

  FDA approved a supplemental application for carvedilol from Dr. Reddy's Laboratories Limited (ANDA) to modify or update the approved product…